- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 14/645 - Secretins
Patent holdings for IPC class C07K 14/645
Total number of patents in this class: 52
10-year publication summary
|
3
|
5
|
4
|
7
|
7
|
2
|
5
|
4
|
10
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Eli Lilly and Company | 3720 |
7 |
| Novo Nordisk A/S | 2278 |
4 |
| Antag Therapeutics ApS | 12 |
4 |
| Adda Biotech Inc. | 6 |
3 |
| Eiger BioPharmaceuticals, Inc. | 40 |
2 |
| Hanmi Pharm. Co., Ltd. | 552 |
2 |
| Sunshine Lake Pharma Co., Ltd. | 570 |
2 |
| The United States Government AS represented by The Department of Veterans Affairs | 1097 |
2 |
| University of Copenhagen | 388 |
2 |
| Shattuck Labs, Inc. | 111 |
2 |
| Zealand Pharma A/S | 241 |
2 |
| Hangzhou Zhongmeihuadong Pharmaceutical Co. Ltd. | 68 |
2 |
| The Board of Trustees of the Leland Stanford Junior University | 6246 |
1 |
| The Trustees of Columbia University in the City of New York | 3524 |
1 |
| Bolder Biotechnology, Inc. | 14 |
1 |
| CEM Corporation | 99 |
1 |
| Han, Jie | 10 |
1 |
| Innovation Ulster Limited | 18 |
1 |
| Jiangnan University | 1480 |
1 |
| Koninklijke Nederlandse Akademie van Wetenschappen | 111 |
1 |
| Other owners | 10 |